Research News

No blood pressure lowering agents prolong survival in diabetes and kidney disease, review shows

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2824 (Published 26 May 2015) Cite this as: BMJ 2015;350:h2824
  1. Susan Mayor
  1. 1London

No blood pressure lowering agents used either alone or in combination prolong survival in adults with diabetes and kidney disease, a meta-analysis published in the Lancet has found.1

Researchers analysed 157 studies comparing blood pressure lowering agents in a total of 43 256 patients with diabetic kidney disease, mostly type 2 diabetes and chronic kidney disease. The trials were identified by searching electronic databases systematically for trials published up to January 2014 that compared several classes of blood pressure lowering drugs, used alone or …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe